Donate
T1International Statement on World Health Assembly Insulin Resolution Meeting

T1International Statement on World Health Assembly Insulin Resolution Meeting

Facebook Google LinkedIn Twitter

The idea of planning insulin and type 1 diabetes advocacy without patient voices and patient representation is coming to an end. Not only do patients bring value to these conversations, but it is our right to be present and involved at every level of policy-making.

We were proud that Cyrine Farhat of Lebanon represented T1International, the #insulin4all movement and people living with type 1 diabetes as one of six speakers at a collaborative virtual event* about a WHA Resolution on Access to Insulin.

The aim of the resolution is to draw the attention of Member States, the World Health Organization (WHO), and other stakeholders to the pressing need for access to insulin, and to request more resources to ensure availability, accessibility, affordability and quality for all people in need of insulin.

We thank Cyrine for her voice, which rang out loud and true. No one could deny what she stated clearly during the event: Access to insulin is a human right. Many speakers reinforced this sentiment. This is progress. We need further progress still, and we need action.

Every country on earth has people living within it who will die without insulin. The virtual event clearly established the need for strong global representation, and that the needs of low and middle income countries must continue to be front and centre. A key highlight was when the Minister of Health of Mali announced new public funding for insulin, proclaimingFree insulin for children and young adults must be a universal right!”.

Mali is a country with a proud history and a rich culture. Like many countries, it is also facing conflict, climate change and poverty, yet they are moving forward and prioritizing people with diabetes. What excuse do countries like the United States have in not doing the same? In our view: None.

We are under no illusion that a World Health Assembly resolution on insulin will change the facts on the ground overnight. However, it will be another tool at our disposable for ensuring our rights as human beings and our dignity are upheld. During the event, the World Health Organization representative emphasized that without a mandate, they cannot take action. They need organizations, countries, and individuals to push them to action. Indeed, that is our plan, and our people-power will continue to do just that.

T1International and #insulin4all advocates have been in the streets protesting for change. We have been in newspapers, on the radio, in film, on television and active on social media. We have been advocating to our governments and to the world that people with diabetes must have access to insulin and their right to health must be recognized. We look forward to continuing to work with the WHO and other partners to pass a World Health Assembly Resolution, and to ensure that the advancement of our human rights is a reality.

*The event was planned and executed by the below organizations.

Related posts:

World Health Organization and Novo Nordisk Foundation - A Conflict of Interest

World Health Organization and Novo Nordisk Foundation - A Conflict of Interest

T1International and other organisations shared a letter today with Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, urging that the World Health Organization reject any funding directly or indirectly from the pharmaceutical industry. The entity already rejects funding from the tobacco and formula milk industry. The letter also asks WHO to push the pharmaceutical industry to lower prices and create sustainable solutions, and to practise more transparency and accountability to the global community that the entity exists to serve. Read more

Global Advocacy Success Series: Cyrine, Lebanon

Global Advocacy Success Series: Cyrine, Lebanon

T1International has provided tools and support to ensure Cyrine’s plans are detailed and realistic, and allowed her to connect with other advocates around the world who can offer support and guidance. Read more

T1International Comment on Application to Add Long-acting Insulin Analogues to WHO EML

T1International Comment on Application to Add Long-acting Insulin Analogues to WHO EML

The WHO justifying inaction by saying it will not be adequate fails to address the issue of manufacturer monopolies and price-gouging. To see a world health leader taking this stance is extremely disheartening. Not to mention, civil society groups, including T1International, have coordinated actions to address the root causes of the issue. If the application is rejected for a third time, the diabetes community will continue to feel that the voices of people with diabetes do not matter and that the WHO is not listening to those who live this reality every day. Read more

World Health Organization Consultation for People Living with Diabetes

World Health Organization Consultation for People Living with Diabetes

The Global Diabetes Compact (GDC) and the Consultation for People Living with Diabetes, gives me hope that there has been a step towards what we as advocates have long been fighting for. We have asked to have our voices truly included and to be treated like experts when it comes to solving global diabetes problems. We hope this is the start of real action and outcomes. Like Dr. Bente shared, it is time to co-create with WHO and move forward by holding their efforts accountable. Read more

There Is No Insulin in Iran

There Is No Insulin in Iran

Shortages of insulin are not something new in Iran, but recently there is no insulin at all. We were shocked by responses from our politicians who said, "The shortage is just for pens and we have plenty of internal production of insulin. People can replace it." However, the types of insulin that are produced in Iran are NPH and R. Few consumers in Iran use NPH. About 70 percent of Iranian people with diabetes use insulin pens. Read more

Representing Latin America’s Insulin Access Needs at the World Health Organization Workshop

Representing Latin America’s Insulin Access Needs at the World Health Organization Workshop

I felt empowered that the voices of those of us living with type 1 diabetes were respectfully listened and taken into account by the WHO. As noted: Patients have power. Being able to represent my country made those words feel real, and it had tremendous value for me. Read more

People with Type 1 Diabetes Take Action After the Explosion in Beirut

People with Type 1 Diabetes Take Action After the Explosion in Beirut

“My first thoughts when it happened was that an earthquake had hit, because the earth shook so hard that I could literally feel tectonic plates shifting. The first thing I did was grab my insulin supplies and run down the stairs.” Read more

An Insulin Resolution is Necessary for Lebanon and the World

An Insulin Resolution is Necessary for Lebanon and the World

Lebanon’s recent financial crisis has caused a dollar shortage that, since September, has restricted the ability of medical supply importers to import vital medical supplies. First it started with masks, gloves, and other protective gear, as well as ventilators and spare parts, and now even essential diabetes supplies are sometimes unavailable. Read more

T1International Statement on COVID-19

T1International Statement on COVID-19

As the world grapples with the effects of a global pandemic, the situation is evolving quickly and the short and long-term impacts are still unclear. What is clear is that the COVID-19 crisis stresses the need to approach healthcare as a human right. The crisis also emphasizes the need for international cooperation to fix global health problems. There must be global solidarity in the fight for #insulin4all and universal access to healthcare. Read more

T1International Statement on Brexit

T1International Statement on Brexit

We stand ready to hold the UK government to account on the provision of healthcare for UK citizens with type 1 diabetes over the coming months and years. We will strongly resist any erosion of the current provision of essential medicine and supplies, medical devices or support services for patients with type 1 diabetes in the UK. Read more

T1International Submission: WHO Independent Global High-Level Commission on NCDs

T1International Submission: WHO Independent Global High-Level Commission on NCDs

We applaud the Commission’s aim to propose bold and practical ways to curb the world’s leading causes of death and illness, and we are in complete agreement with the WHO’s support for universal health care. Patients and organizations supporting #insulin4all are eager to assist you and the staff at the World Health Organization. Read more